Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Dec 5, 2023 to Dec 5, 2023
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| Office of Acquisition Managementt Policy | RHO Federal Systems Division Inc. | Dec 5, 2023 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
Effective Date
Aug 22, 2023
Expires
Effective: Aug 22, 2023
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ActiveCLINICAL TRIAL PLANNING AND EXECUTION (CTPE)
Effective Date
Sep 27, 2023
Expires
Effective: Sep 27, 2023
CLINICAL TRIAL PLANNING AND EXECUTION (CTPE)
ActiveINTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.
Effective Date
Sep 27, 2022
Expires
INTEGRATED SAFETY SUMMARY REPORT OF CLINICAL STUDIES ASSESSING SAFETY OF INFLUENZA VACCINES ADMINISTERED WITH AS03 OR MF59 ADJUVANT.
ActiveSUPPORT & ANALYSIS FOR CLINICAL TRIAL STUDIES
Effective Date
Jun 10, 2022
Expires
Effective: Jun 10, 2022
SUPPORT & ANALYSIS FOR CLINICAL TRIAL STUDIES
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis